J
Jamie Lopez Bernal
Researcher at Public Health England
Publications - 59
Citations - 7306
Jamie Lopez Bernal is an academic researcher from Public Health England. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 15, co-authored 33 publications receiving 1902 citations. Previous affiliations of Jamie Lopez Bernal include University College London & University of London.
Papers
More filters
Journal ArticleDOI
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal,Nick Andrews,Charlotte Gower,Eileen Gallagher,Ruth Simmons,Simon Thelwall,Julia Stowe,Elise Tessier,Natalie Groves,Gavin Dabrera,Richard H. Myers,Colin Campbell,Gayatri Amirthalingam,Matt Edmunds,Maria Zambon,Kevin E. Brown,Susan Hopkins,Meera Chand,Mary Ramsay +18 more
TL;DR: The B.617.1.2 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus disease 2019 (Covid-19), has contributed to the development of the disease.
Journal ArticleDOI
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Nick Andrews,Julia Stowe,Freja C M Kirsebom,Samuel E. Toffa,T S Rickeard,Eileen Gallagher,Charlotte Gower,Meaghan Kall,Natalie Groves,Anne Marie O’Connell,David Simons,Paula Blomquist,Asad Zaidi,S. Nash,Nurin Iwani Binti Abdul Aziz,Simon Thelwall,Gavin Dabrera,R. Myers,Gayatri Amirthalingam,Saheer E. Gharbia,Jeffrey C. Barrett,Richard Elson,Shamez N Ladhani,Neil M. Ferguson,Maria Zambon,Colin Campbell,Kevin K. Brown,Susan Hopkins,Meera Chand,Mary Ramsay,Jamie Lopez Bernal +30 more
TL;DR: Primary immunization with two doses of ChAdOx1 nCoV-19 or BNT162b2 vaccine provided limited protection against symptomatic disease caused by the omicron variant, but that protection waned over time.
Journal ArticleDOI
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.
Anika Singanayagam,Monika Patel,Andre Charlett,Jamie Lopez Bernal,Vanessa Saliba,Joanna Ellis,Shamez N Ladhani,Maria Zambon,Robin Gopal +8 more
TL;DR: Probability of culturing virus declines to 8% in samples with Ct > 35 and to 6% 10 days after onset and it is similar in asymptomatic and symptomatic persons.
Journal ArticleDOI
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg,Neil M. Ferguson,Seth Flaxman,Wes Hinsley,Meaghan Kall,Paula Blomquist,N. A. Aziz,Kattie Harman,Sebastian Funk,Meera Chand,Azra C. Ghani,Shaun R. Seaman,Daniela De Angelis,S. Nash,H. Webster,Nick Andrews,Jamie Lopez Bernal,Samir Bhatt,Asad Zaidi,Erik M. Volz,Nur Adilah Abdul Aziz,Sam Abbott,Russell Hope,Andre Charlett,Gavin Dabrera,Anne M. Presanis,Simon Thelwall +26 more
TL;DR: The risk of severe outcomes following SARS-CoV-2 infection is substantially lower for omicron than for delta, with higher reductions for more severe endpoints and significant variation with age.
Journal ArticleDOI
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
Simon de Lusignan,Simon de Lusignan,Jienchi Dorward,Jienchi Dorward,Ana Correa,Ana Correa,Nicholas R Jones,Oluwafunmi Akinyemi,Gayatri Amirthalingam,Nick Andrews,Rachel Byford,Gavin Dabrera,Alex J. Elliot,Joanna Ellis,Filipa Ferreira,Jamie Lopez Bernal,Cecilia Okusi,Mary Ramsay,Julian Sherlock,Gillian E. Smith,John H. H. Williams,Gary Howsam,Maria Zambon,Mark Joy,FD Richard Hobbs +24 more
TL;DR: People living in urban areas versus rural areas and in more deprived areas and people with chronic kidney disease were more likely to test positive in the adjusted analysis, and active smoking was linked with decreased odds of a positive test result.